NURPF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Neuren Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 8.875 USD

Market Cap: $1.2B

N	Neuren Pharmaceuticals Ltd OTC:NURPF	AU
	Hydrogenpro ASA OSE:HYPRO	NO
T	TD Synnex Corp F:SUX	US
A	AMP Ltd XBER:AMP	AU
H	Hanmi Financial Corp F:HF7N	US
W	WideOpenWest Inc SWB:WU5	US
T	Tourmaline Oil Corp SWB:08T	CA
G	Goldman Sachs Group Inc F:GOS	US
	Just Kitchen Holdings Corp XTSX:JK	CA
	CTO Realty Growth Inc F:8QB0	US
	elf Beauty Inc NYSE:ELF	US
P	Petrofac Ltd OTC:POFCF	JE

Profitability Summary

Neuren Pharmaceuticals Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Exceptional Operating Margin

45%

Strong 3Y Average Operating Margin

75%

Operating Margin is Increasing

-2% > 45%

Exceptional Net Margin

40%

Strong 3Y Average Net Margin

60%

Net Margin is Increasing

1% > 40%

Exceptional Free Cash Flow Margin

163%

Strong 3Y Average Free Cash Flow Margin

71%

Free Cash Flow Margin is Increasing

23% > 163%

Low ROE

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

821%

ROIC is Increasing

-15% > 23%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.